Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Wounds and Injuries or Venous Thromboembolism
and you are
between 18 and 65
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This is a phase II, pragmatic, prospective, randomized, double-blind, adaptive clinical trial examining the efficacy of statins and aspirin in the reduction of acute lung injury and venous thromboembolism in patients with fibrinolysis shutdown.

Provided treatments

  • Drug: Aspirin and Rosuvastatin
  • Drug: Placebo (for Aspirin and Rosuvastatin)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02901067. The sponsor of the trial is Denver Health and Hospital Authority and it is looking for 440 volunteers for the current phase.
Official trial title:
STAT (STatins and Aspirin in Trauma) Trial: A Phase II, Pragmatic, Prospective, Randomized, Double-blind, Adaptive Clinical Trial Examining the Efficacy of Statins and Aspirin in the Reduction of Acute Lung Injury and Venous Thromboembolism in Patients With Fibrinolysis Shutdown